Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 89 Shiller PE Ratio is 16.77 as of Aug. 06, 2026, which is 49% below its 10-year median of 32.78. GuruFocus rates CSMYF with a GF Score™ of 89/100 and a GF Value™ of $52.01 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 240 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks better than 58.75% on this metric.
The historical rank and industry rank for COSMOS Pharmaceutical's Shiller PE Ratio or its related term are showing as below:
CSMYF'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 18.25 Med: 32.78 Max: 55.97
Current: 19.61
During the past years, COSMOS Pharmaceutical's highest Shiller PE Ratio was 55.97. The lowest was 18.25. And the median was 32.78.
CSMYF's Shiller PE Ratio is ranked better than 58.75% of 240
companies
in the Healthcare Providers & Services industry
Industry Median: 23.71
vs CSMYF: 19.61
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
COSMOS Pharmaceutical's adjusted earnings per share data for the three months ended in Feb. 2026 was $0.659. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $2.21 for the trailing ten years ended in Feb. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
COSMOS Pharmaceutical (OTCPK:CSMYF) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
COSMOS Pharmaceutical Shiller PE Ratio Related Terms
COSMOS Pharmaceutical Shiller PE Ratio Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical Shiller PE Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical Shiller PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Shiller PE Ratio falls into.
COSMOS Pharmaceutical Shiller PE Ratio Calculation
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
COSMOS Pharmaceutical (CSMYF) has a Shiller PE Ratio of 16.77 as of Aug. 06, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on COSMOS Pharmaceutical and its competitors. This is 49% below median its historical median of 32.78. Over the past decade, COSMOS Pharmaceutical's Shiller PE Ratio has ranged from 18.25 to 55.97. According to the industry distribution chart, COSMOS Pharmaceutical ranks #99 out of 240 companies in the Healthcare Providers & Services industry, placing it in the top 41.2%.
Is COSMOS Pharmaceutical's Shiller PE Ratio too high?
COSMOS Pharmaceutical's current Shiller PE Ratio of 16.77 is 49% below median its 10-year median of 32.78. Over the past 10 years, this metric has ranged from a low of 18.25 to a high of 55.97. The Healthcare Providers & Services industry median Shiller PE Ratio is 23.71. COSMOS Pharmaceutical's value of 16.77 is 29.3% below this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #99 out of 240 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, COSMOS Pharmaceutical has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Shiller PE Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #99 out of 240 companies for Shiller PE Ratio. This puts COSMOS Pharmaceutical in the upper half of its industry. The industry median Shiller PE Ratio is 23.71. COSMOS Pharmaceutical's value of 16.77 is 29.3% below this benchmark. Historically, COSMOS Pharmaceutical's own Shiller PE Ratio has ranged from 18.25 to 55.97 over the past decade. While the company's 10-year median is 32.78 vs. the industry median of 23.71, COSMOS Pharmaceutical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Healthcare Providers & Services company?
The median Shiller PE Ratio among Healthcare Providers & Services companies is 23.71, based on 240 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Shiller PE Ratio of 16.77 is 29.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median Shiller PE Ratio is 23.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Shiller PE Ratio is 16.77, which is 49% below median its own 10-year median of 32.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $52.01, compared to a current price of $37.06 — trading 28.7% below its estimated fair value. The current Shiller PE Ratio is 16.77, which is 49% below median its 10-year median of 32.78 and 29.3% below the Healthcare Providers & Services industry median of 23.71. COSMOS Pharmaceutical's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Shiller PE Ratio is 16.77 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 28.7% below its estimated GF Value™ of $52.01.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for CSMYF:
Shiller PE Ratio: 16.77 (49% below median its 10-year median of 32.78)
GF Value™: $52.01 vs. price of $37.06 (28.7% below fair value)
Industry Position: 29.3% below the Healthcare Providers & Services median (#99 of 240)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
89GF Score
Get the complete analysis for CSMYF
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
